首页> 美国卫生研究院文献>Metabolites >A New Classification Method of Metastatic Cancers Using a 1H-NMR-Based Approach: A Study Case of Melanoma Breast and Prostate Cancer Cell Lines
【2h】

A New Classification Method of Metastatic Cancers Using a 1H-NMR-Based Approach: A Study Case of Melanoma Breast and Prostate Cancer Cell Lines

机译:基于1 H-NMR的转移癌新分类方法:黑色素瘤乳腺癌和前列腺癌细胞系的研究案例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

In this study, metastatic melanoma, breast, and prostate cancer cell lines were analyzed using a H-NMR-based approach in order to investigate common features and differences of aggressive cancers metabolomes. For that purpose, H-NMR spectra of both cellular extracts and culture media were combined with multivariate data analysis, bringing to light no less than 20 discriminant metabolites able to separate the metastatic metabolomes. The supervised approach succeeded in classifying the metastatic cell lines depending on their glucose metabolism, more glycolysis-oriented in the BRAF proto-oncogene mutated cell lines compared to the others. Other adaptive metabolic features also contributed to the classification, such as the increased total choline content (tCho), UDP-GlcNAc detection, and various changes in the glucose-related metabolites tree, giving additional information about the metastatic metabolome status and direction. Finally, common metabolic features detected via H-NMR in the studied cancer cell lines are discussed, identifying the glycolytic pathway, Kennedy’s pathway, and the glutaminolysis as potential and common targets in metastasis, opening up new avenues to cure cancer.
机译:在这项研究中,使用基于H-NMR的方法分析了转移性黑色素瘤,乳腺癌和前列腺癌细胞系,以研究侵袭性癌症代谢组的共同特征和差异。为此,将细胞提取物和培养基的H-NMR谱图与多变量数据分析相结合,揭示了不少于20种能够分离转移性代谢组的判别性代谢物。有监督的方法成功地根据转移的细胞系的葡萄糖代谢对它们进行了分类,与其他细胞相比,BRAF原癌基因突变的细胞系更倾向于糖酵解。其他适应性代谢特征也有助于分类,例如总胆碱含量(tCho)的增加,UDP-GlcNAc检测以及葡萄糖相关代谢物树的各种变化,从而提供了有关转移代谢组状态和方向的更多信息。最后,讨论了在研究的癌细胞系中通过H-NMR检测到的常见代谢特征,确定了糖酵解途径,肯尼迪途径和谷氨酰胺分解是转移的潜在靶点和共同靶点,从而开辟了治疗癌症的新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号